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The development of affinity resins for the isolation of angiotensin II receptors from adrenal
fasciculata cells is described. The approach is based on the avidin-biotin interaction. The
advantages ofthe technique are delineated.
INTRODUCTION
It has been recognized for some time that the production ofaldosterone by adrenal
glomerulose cells is regulated by adrenocorticotropic hormone (ACTH) and angioten-
sin II. More recently it has become clear that glucocorticoid biosynthesis in fasciculata
cells is also stimulated by angiotensins [1].
Bovine adrenal fasciculata cells respond to ACTH, angiotensin I (Al), angiotensin
II (All), and angiotensin III (AIII) with formation of corticosteroids [2]. While the
response to ACTH is mediated by cAMP, the stimulation by the angiotensins is not
accompanied by an increase in the cyclic nucleotide [3]. Accordingly, fasciculata cells
contain two classes of receptors that mediate steroid production via different
pathways.
Hormonal stimulation of aldosterone in the glomerulosa cell requires extracellular
potassium [4] and calcium [5,6]. Canine glomerulosa cells contain both high affinity
(Ka = 3.3 x 109M-') and lower affinity (Ka = 2.5 x 108M-') binding sites for 1251 All
[7] with the high affinity sites accounting for 25-33 percent of the total receptor
population.
All stimulation of bovine fasciculata cells to produce corticosteroids is less well
understood than aresimilar events in glomerulosa cells. Although Peytremann et al.[1]
reported that cAMP production is elicited by All, more recent evidence supports the
view that cAMP is not a second messenger in All stimulation of adrenal cells [3].
Hormonal stimulation of steroid production in fasciculata cells requires extracellular
calcium [3]. Whereas potassium is essential for steroidogenesis in the glomerulosa
cells, it does not affect steroid production in the fasciculata cell [3].
Fasciculata cells contain specific angiotensin receptors which bind 125I labeled All
saturably and with high affinity. Binding studies have identified a single class of
binding sites with Ka values of 0.2 x 108M-1 for All and 0.7 x 108M-1 for AIII [3].
ACTH does not displace labeled All or AIII from the cells, providing evidence for the
specificity ofthe angiotensin receptors.
Several attempts have been made to identify All receptors in various tissues by
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cross-linking radiolabeled photoaffinity derivatives of All to receptors or by cross-
linking '25I All using disuccinimidyl suberate. Solubilization of the covalently linked
complexes followed by separation of the materials by SDS-PAGE under reducing
conditions has produced two estimates for the molecular weight ofthe receptor. An M,
of 116,000 was reported for the cross-linked receptor from rat adrenal[8], while M,
68,000 was found for the photoaffinity labeled receptor from dog adrenal and uterus
[9] and for the cross-linked preparation from rabbit liver [10].
Although some functional properties of the All receptors have been characterized
with isolated cells and particulates, little is known regarding their molecular character-
istics. This appears to be partly due to their instability. Apparently intact solubilized
receptor capable ofspecifically binding angiotensin ligands has been obtained from rat
adrenal glomerulosa particles using the zwitterionic detergent 3-[(3-cholamidopro-
pyl)-dimethylammonio]-l-propane-sulfonate ("Chaps") [11]. Using 5 mM "Chaps,"
45 percent of membrane proteins and 50 percent of the All receptors could be
solubilized. Binding assays were performed at a "Chaps" concentration of2 mM since
there was inhibition of binding at higher detergent concentrations. The solubilized
receptor preparation was very unstable, losing 50 percent of its binding activity when
stored at -700C for ten days. Loss ofactivity at 400C was more rapid. The solubilized
receptors retained the properties ofthe particulate receptor as concerns binding ofAll
and congeners.
In connection with our long-standing interest in hormones that are involved in the
stimulation of steroidogenesis in adrenal fasciculata cells, we have initiated an
investigation aimed at the isolation ofAll receptors from bovine fasciculata cells, using
affinity chromatography based on the avidin-biotin approach [12]. In this paper, we
describe studies relating to the preparation ofan affinity column for the purification of
these receptors.
To establish the feasibility ofthis approach, several fundamental criteria have to be
met. The biotin-containing analogs ofAll must be able to interact with All receptors;
they must form strong complexes with suc-avidin; and they must be capable of
interacting simultaneously with suc-avidin and All receptors in order to be suitable
ligands for affinity chromatography. In this paper, we describe the synthesis and
characterization oftwo potential ligands.
EXPERIMENTAL PREPARATION OF COMPOUNDS
Avidin was prepared from hens' egg white by the method of Orr [13] and was
converted to suc-avidin in the manner described previously [14].
N"-tert-butoxycarbonyl-N-biotinyl-L-lysine (Na-tert-butoxycarbonyl-biocytin)
was prepared from N'-tert-butoxycarbonyl-L-lysine and the N-hydroxysuccinimido
ester ofbiotin. The material was recrystallized from methanol-water; m.p. 136-138°C;
[a] 21 + 39.60 (c 0.975, MeOH).
Anal. Calcd. for C21H36N406S C, 53.37; H, 7.68; N, 11.86
Found C, 53.47; H, 7.88; N, 11.87
The N-hydroxysuccinimido ester of the title compound was prepared in the usual
manner and was recrystallized from isopropanol/acetone/ethyl acetate; m.p. 111-
1I3°C;
Anal. Calcd. for C25H39N508S C, 52.71; H, 6.90; N, 12.29
Found C, 52.56; H, 7.01; N, 12.14
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N-tert-butoxycarbonyl-N'-6-(biotinylamido)hexyl-L-lysine This compound was
prepared from N'-tert-butoxycarbonyl-L-lysine and the N-hydroxysuccinimido ester
of 6-(biotinylamido)hexanoic acid and was recrystallized from methanol/water; m.p.
123-125OC; [a] 21 + 31.40 (c 1.04, MeOH).
Anal. Calcd. for C27H47N507S C, 55.36; H, 8.09; N, 11.96
Found C, 55.35; H, 8.26; N, 12.02
The N-hydroxysuccinimido ester of the title compound was prepared in the usual
manner and was recrystallized from isopropanol/acetone/ethyl acetate; m.p. 112-
114°C;
Anal. Calcd. forC31H50N6O9S C, 54.53; H, 7.38; N, 12.31
Found C, 54.43; H, 7.51; N, 12.21
[Biocytin'Jangiotensin II This compound was prepared from H-Arg-Val-Tyr-
Val-His-Pro-Phe-OH(AIII) [15] and N-hydroxysuccinimido Na-tert-butoxycarbonyl-
biocytin followed by deprotection with trifluoroacetic acid; homogeneous on high
performance liquid chromatography (HPLC); amino acid ratios in acid hydrolysate;
Lys0.98Arg1.01Val2.04Tyr .05HisO.88Prol.04Phel.00.
[N'-6-(biotinylamido)hexyl-L-lysine'] angiotensin II This compound was pre-
pared from (AIII) and N-hydroxysuccinimido N'-tert-butoxycarbonyl-N'-6(biotin-
ylamido)hexyl-L-lysine followed by deblocking with trifluoroacetic acid; homogeneous
on HPLC; amino acid ratios in acid hydrolysate; Lys0.93Arg.03Val2.02TyrI.03His0.93
Pro1.03Phel.03-
ANALYTICAL METHODS AND BIOASSAYS
Peptides were hydrolyzed for 20 hours at 110°C in 6 N hydrochloric acid containing
1 percent (v/v) phenol. Amino acids in the hydrolysates were determined in a Waters
instrument by the Pico-Tag method. HPLC of the peptides was conducted with the
same instrument using a Bondapak C18 column with the following solvent systems:
(pump A) 0.1 percent phosphoric acid; (pump B) 0.1 percent phosphoric acid:acetoni-
trile (1:1). The linear gradient was 10-60 percent pump B over 25 minutes with a
pumping speed of 2 ml/minute. Samples of approximately 10 ,g were injected. The
rates of dissociation of the suc-avidin-angiotensin analog complexes were determined
as described previously [16]. The preparation ofcalf adrenal fasciculata cells and the
steroid bioassays were conducted as described previously [17].
RESULTS
We have synthesized two biotinylated derivatives ofAll: i.e., [biocytin'] angiotensin
II and [NE-6-(biotinylamido)hexyllysine'], angiotensin II. In these analogs, the
N-terminal aspartic acid ofAll is replaced by a lysine residue whose E-amino group is
acylated with either biotin or 6-(biotinylamido)hexanoic acid. These analogs were
selected because the extensive literature [18] on the biological activity of All
derivatives indicates that the N-terminal amino group is important for biological
activity. The analogs differ with respect to the position of biotin, which in analog I is
attached directly to the e-amino group of the N-terminal lysine, whereas in analog II
an aminohexanoic acid spacer is interspaced between the e-amino group of lysine and
the biotin. The structures of All, AIII, and the two analogs are illustrated in Fig. 1.
The two peptides were synthesized by coupling Na-tert-butoxycarbonylbiocytin or
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H-Arg-Val-Tyr-Val-His-Pro-Phe-OH
VaI5 Angiotensin III
H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-OH
Val5 Angiotensin 11
H-Bct-Arg-Val-Tyr-Val-His-Pro-Phe-OH
Bct1, VaI5 Angiotensin 11
H-Lys(BAH)-Arg-VaI-Tyr-Val-His-Pro-Phe-OH
FIG. 1. Structures ofvariousangiotensin deriv-
Lys(BAH)1, Val5 Angiotensin 11 atives.
N"-tert-butoxycarbonyl-N'-6-(biotinylamido)hexyllysine to AIII, using theN-hydrox-
ysuccinimide ester procedure. The protected intermediates were deprotected with
trifluoroacetic acid. The structures of biocytin and NE-6-(biotinylamido)hexyllysine
are illustrated in Fig. 2. The biotinylated peptides were characterized by elemental
analysis, high performance liquid chromatography (results notshown), and amino acid
analyses of their acid hydrolysates. Judged by these criteria, the analogs were
homogeneous.
A comparison of the steroidogenic activity in bovine fasciculata cells of the two
analogs with that ofAll is illustrated in Fig. 3. Both analogs elicit essentially the same
maximal stimulation as All but when compared at the level of 50 percent stimulation
are approximately 10 percent as active as All.
We have determined the ability of the analogs to bind to succinoylavidin (suc-
avidin) and have assessed thedissociation rateoftheanalog-suc-avidin complexes. The
k_Is-' values are 2.6 x l0' for [biocytin'] All and 2.2 x 107 for [NE-6-
0
,C
H-N N-H
HN-CO-(CH2)4-C CH2
(CH2)4
+
H3N-C-COO-
Biocytin (Bct)
0
H-N N-H
H-C C-H
HN-CO-(CH2)5-NH-CO-(CH2)4-U1CN C1H2 I ~~~~~H s~
(CH2)4
+
H3N-C-C00_
NE-6-(biotinylamido)-hexyllysine (Lys(BAH))
FIG. 2. Structures of biocytin and [NE-6-(bioti-
nylamido)hexyllysine' ].
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(biotinylamido)hexyllysine') All. These values correspond to a t/2 of 30 and 36 days,
respectively, and demonstrate that the analogs bind firmly to suc-avidin. The effect of
suc-avidin on the steroidogenic activity of the analogs (Fig. 3) shows that while the
[biocytin') All is significantly inhibited at a suc-avidin-analog ratio of2:1, the activity
ofthe analog embodying the aminohexyl spacer arm is not affected by suc-avidin even
at a 5:1 ratio.
DISCUSSION
We are attempting the isolation ofAll receptors from bovine fasciculata cells by the
avidin-biotin technology, which we have developed and applied successfully to the
isolation of highly purified insulin receptors from human placenta [19]. The avidin-
biotin approach to the isolation of hormone receptors is based on the very strong
non-covalent interaction (Kd - 10-'5M) between the egg-white protein avidin and
biotin. The principle of the procedure is illustrated in Fig. 4. Two components-i.e.,
Sepharose-immobilized succinoyl avidin (I) and a biotinylated hormone (II)-are
mixed to form the affinity column (III). It is of importance to eliminate, as much as
possible, nonspecific interactions between the affinity resin and constituents in extracts
containing solubilized receptors. We have observed that avidin, a basic protein, binds
avidly and nonsaturably to rat liver plasma membranes, which constitutes an undesir-
able property. Extensive succinoylation of avidin to form succinoylavidin (suc-avidin)
markedly reduces nonspecific interactions, and, as a consequence, we employ suc-
avidin in our studies [14]. Succinoylation ofavidin reduces the halftimeofdissociation
ofthe avidin-biotin complex from 200 to 127 days [20].
A series offundamental questions have to beanswered prior toattempting the actual
isolation of receptors by the avidin-biotin approach. These are (I) Is it possible to
prepare biotinylated analogs of the hormone that exhibit high specificity and affinity
for the receptor? (2) Do such analogs bind to suc-avidin, and what is the dissociation
rate of the biotinylhormone-suc-avidin complexes? (3) Can the analogs bind simulta-
neously to suc-avidin and All receptors? Studies designed to answer these questions
are discussed below.
As can be seen in Fig. 3, [biocytin'] angiotensin II and [NE-6-(biotinylamido)hexyl-
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FIG. 4. Formation of affinity resin (III) from immobilized suc-avidin (I), and biotinylated AII (II).
Dashed lines represent non-covalent bonds.
lysine'] angiotensin II stimulate corticoid biosynthesis offasciculata cells and thus are
capable of binding to cell surface receptors. The dissociation rates of the suc-avidin
complexes of the two analogs demonstrate that they bind very strongly to suc-avidin.
The structural differences between the analogs are not reflected in the dissociation
behavior oftheir complexes with suc-avidin.
From the point of view of affinity chromatography, it is important to assess the
ability of the analogs to bind simultaneously to both the All receptors and to
suc-avidin. Once we establish that stable complexes are formed between the biotin-
containing analogs and suc-avidin, we measure the ability of the analogs to stimulate
steroidogenesis in the presence of an excess of suc-avidin. Since such experiments are
performed in the presence of an excess of suc-avidin, it is assumed that under these
conditions the assay solutions do not contain free analog: i.e., analog that is not
non-covalently attached to suc-avidin. As can be seen in Fig. 3, the addition of
suc-avidin to the assay solutions exerts a different effect on the steroidogenic response
of the two analogs. At a molar ratio of 2:1 of suc-avidin to [biocytin'] All,
steroidogenesis is lowered to 1 percent that of the All control, but under the same
conditions, the activity of [NE-6-(biotinylamido)hexyllysine'] All is not decreased.
Increasing the suc-avidin concentration to a molar ratio of 5:1 does not potentiate the
inhibition with either analog, indicating that no free ligand is present in the assay
mixture at the 2:1 ratio. Since suc-avidin contains four biotin binding sites per mol, the
mol ratios, in terms ofbinding sites, are actually 8 and 20:1, respectively. These results
show that both analogs have the ability to interact simultaneously with suc-avidin and
the All cell receptors. We interpret the difference in the behavior ofthe two analogs in
steric terms. Thegreater distance between the cell surface receptors and the suc-avidin
in [N'-6-(biotinylamido)hexyllysinel] angiotensin II eliminates the steric impediment
that appears to exist with [biocytin'] angiotensin II. We have observed similar effects
with biotinylated insulins [21]. Steroidogenesis induced by underivatized All is not
inhibited by suc-avidin, in agreement with observations with insulin and ACTH, where
the bioeffect ofthe underivatized hormones was likewise unaffected by suc-avidin.
On the basis of the above observations, the construction of an avidin-biotin based
affinity resin for All receptor isolation (Fig. 4) simply involves mixing of immobilized
suc-avidin [19] (I) with the [NE-6-(biotinylamido)hexyllysinel] All (II), resulting in
the non-covalent attachment ofthe ligand to the biotin binding sites on the suc-avidin.
Theobservation that [NE-6-(biotinylamido)hexyllysinel] All retains biological activity
in the presence ofan excess ofsuc-avidin (Fig. 3) suggests that affinity resins in which
this ligand is attached to immobilized suc-avidin will bind solubilized All receptors.
The availability offunctional, soluble angiotensin receptors from adrenal glomerulosa
cells [11] and of All specific affinity columns provides the tools for experiments
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FIG. 5. Application of the avidin-biotin system to the isolation of hormone receptors. Dashed lines
represent non-covalent bonds.
designed to isolate angiotensin II receptors. Feasible isolation protocols are illustrated
in Fig. 5. In method A, soluble receptor (R) is percolated through an affinity column of
the type described to form the complex shown in the center of Fig. 5. The column is
then exhaustively washed to removecontaminating materials. Alternatively, the ligand
[NE-6-(biotinylamido)hexyllysine'] All can be added to a solution of solubilized
receptor to form the soluble complex BHR. Percolating a solution containing this
complex through a column of immobilized suc-avidin as in B will result in the
formation of the same complex obtained by method A. Both these schemes have been
used for the isolation of insulin receptors from human placenta [19; unpublished
results]. Removal of functional, purified insulin receptor from affinity resins was
achieved by eluting the column with pH 5.0 acetate buffer containing 1 M sodium
chloride [22]. The replacement ofbiotin in the ligand BHR by a biotin analog such as
dethiobiotin that exhibits weaker affinity for suc-avidin than biotin provides a route to
the isolation ofreceptor-ligand complexes as illustrated in D. Such an approach would
permit dissociation of the receptor-ligand complex from the column by 20 mM biotin
which will occupy the open sites on the suc-avidin.
The development ofaffinity resins by the avidin-biotin approach offers the following
advantages:
1. Attachment of biotin to the hormone is targeted and, thus, provides a uniform
site for receptor binding.
2. Hormone ligands are prepared by simple, well-defined solution methods which
can be monitored accurately.
3. Formation ofthe affinity resin is highly specific (avidin-biotin interaction) and is
achieved by simply mixing immobilized avidin derivatives with the ligand.
4. The amount of ligand on the column can be varied at will to achieve optimal
operation, since the interaction ofthe components is quantitative.
5. The technique can be readily scaled up for production of larger quantities of
receptors.
6. Once the technique is worked out for a particular situation, it is highly
reproducible.
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7. In theory, the technique is applicable to any receptor whose affector can be
biotinylated without destruction ofbiological function.
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